Purchase Order 75N93023P01279
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit organization, in the amount of $113,936.00. The award is for the delivery of Olink's integrated fluidic circuits and reagent kits to support the Viral Pathogenesis and Evolution Section's research into the development of universal influenza and SARS-CoV-2 vaccines. The...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $20,041.31 firm-fixed-price purchase order to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of four Olink Target 48 Cytokine/Immune Surveillance Bundles, which support the agency's biomedical research missions. Olink Proteomics holds a significant five-year Indefinite Delivery Contract...
- This is a firm fixed price purchase order for $34,902.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Olink Proteomics AB, a foreign-owned for-profit entity based in Sweden. The contract is for the delivery of Olink Proteomics' proprietary Inflammation reagent kits and Dynamic Array chips, which support multiplex protein biomarker analysis. This purchase order was awarded under simplified acquisition procedures...
- This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics AB, a foreign-owned for-profit manufacturer based in Sweden. The $85,000.00 contract is for the delivery of 10 inflammation reagent kits and associated array chips to support NIAID's biomedical research efforts, particularly in the areas of cancer, cardiovascular disease, infectious...
- This is a firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of Olink Explore HT Reagent Kits, specialized biological and reagent materials used in advanced proteomics research. The contract has a ceiling value of $24,961.31 and a period of performance through September 17, 2025. Olink...
- The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a $198,740.56 firm fixed price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for Olink Explore 3072 reagent kits. The contract is for the delivery of these reagents by September 6, 2023. Olink Proteomics has a history of providing various proteomics instruments, reagents, kits, analysis services,...
- This is a firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $98,392.48 contract is for the delivery of the Olink Explore 3072 Proteomics Screening Kit, which supports the agency's biomedical research missions in areas such as aging, cancer, and neurodegenerative diseases. Olink Proteomics has a significant...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging awarded a firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for an EXPLORE 3072 Reagent Kit. The contract has a potential value of $184,037.60 and a completion date of August 31, 2022. Olink Proteomics has been awarded numerous federal contracts from agencies such as NIH, FDA, and Department of Veterans Affairs to...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $14,531.69 contract is for the provision of Olink's proprietary proteomics instruments, reagent kits, integrated fluidic circuits, and analytical services to support biomedical research missions across the NIH, including aging, cancer, neurodegenerative diseases, diabetes, and infectious diseases. Olink...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for a PCR-based Proximity Extension Assay system. The contract has a period of performance from September 29, 2025, to September 28, 2026, with a ceiling value of $249,732.24. The assay system will be used by NIAID's Viral...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $246,214 firm fixed price purchase order to Olink Proteomics Inc. to deliver Olink reagent kits and protein expression instrumentation. Specifically, the contract calls for 30 units of the Olink Target 96 Inflammation Kit, 20 units of the Olink Target 96 Immune Response Kit, and 51 units of the Olink 96.96 IFC for Protein Expression to be delivered to the agency's location in Bethesda, Maryland by December 31, 2023. The solicitation sought these specific Olink-manufactured laboratory products to support the National Institute of Allergy and Infectious Diseases' research efforts studying inflammation and immune response. No subcontractors or set aside designations were identified.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
OLINK REAGENT KITS AND PROTEIN EXPRESSION | RFQ-NIH-NIAID-2182122 | Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases | Solicitation 1/1 | 8/23/23, 5:28 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $246.2k | 9/13/23 |